Specific inhibition by prostaglandin D2 and its metabolites of lysozyme synthesis in mouse macrophage-like cell line, Mm-1.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1985-03-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0167-4889(85)90134-XPMID 3855662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro.

  1983cited by this paper
• Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation.

  1983cited by this paper
• Prostaglandin D2, a potential antineoplastic agent.

  1982cited by this paper
• Mechanisms of inhibition of mouse myeloid leukemic cell differentiation by prostaglandin F2 alpha.

  1982cited by this paper
• Regulation of prostaglandin synthesis during differentiation of cultured mouse myeloid leukemia cells

  1980cited by this paper
• Characterization of lysozyme synthesized by differentiated mouse myeloid leukemia cells.

  1979cited by this paper
• Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells

  1979cited by this paper
• Induction of lysosomal enzyme activities with glucocorticoids during differentiation of cultured mouse myeloid leukemia cells.

  1977cited by this paper
• Prostaglandin d2 as a potential antithrombotic agent.

  1975cited by this paper
• Hormonal regulation of the hepatic messenger RNA levels for alpha2u globulin.

  1975cited by this paper
• Stimulation of human platelet adenylate cyclase by prostaglandin D2.

  1974cited by this paper
• Prostaglandin D2 inhibits the aggregation of human platelets.

  1974cited by this paper
• Spontaneous development of macrophage-like cells in a culture of myeloid leukemia cells.

  1973cited by this paper
• Differentiation of a cell line of myeloid leukemia

  1969cited by this paper
• SERUM AND URINARY LYSOZYME (MURAMIDASE) IN MONOCYTIC AND MONOMYELOCYTIC LEUKEMIA

  1966cited by this paper
• A convenient, rapid and sensitive method for measuring the incorporation of radioactive amino acids into protein.

  1960cited by this paper

• Optimum dietary protein‐to‐energy ratio for juvenile whiteleg shrimp, Litopenaeus vannamei, reared in a biofloc system

  2018cites this paper
• Prostaglandin J2--anti-tumour and anti-viral activities and the mechanisms involved.

  1990cites this paper
• Selective inhibition of cytokine-induced lysozyme activity by tetanus toxin in the GG2EE macrophage cell line

  1989cites this paper
• Mast Cells and Newly-Generated Lipid Mediators

  1988cites this paper
• Prostaglandins in Cancer Research

  1987cites this paper
• Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and delta 12-prostaglandin J2 in nuclei.

  1987cites this paper
• Regulation by Prostaglandins of Differentiation of Mouse Myeloid Leukemia M1 Cells

  1987cites this paper
• Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition.

  1986cites this paper
• [Two mechanisms of prostaglandin actions: prostaglandin receptor and transport].

  1986cites this paper